Bueno Drop® is used like a natural complementary therapy that stimulates the inmunitary system allowing to improve the quality and the time of the oncological patient's life
Argentina, Argentine Republic (Press Release) October 26, 2007 --
Bueno Drop® is used like a natural complementary therapy that stimulates the inmunitary system allowing to improve the quality and the time of the oncological patient's life. Given the contribution in essential nutrients as the magnesium, the vitamin C and the active principles of the extract of Rosmarinus officinales, Baccharis articulata and Achyrocline satureioides.
From the birth of the oncology, in the years 60, different treatments were designed to attack the cancer. They combined surgeries, radiotherapies, chemotherapies, hormonotherapies and immunotherapies, that which allowed important advances.
"Today is possible to cure more some tumors and to try and to alleviate well most of the sick persons", assures doctor Eduardo Morgenfeld, director of Attention to the Patient of the Oncological Institute Henry Moore. However, it clarifies that to be able to speak of "progress" in the cure, one should analyze that happened tumor by tumor.
"It was possible to change the natural history of relatively uncommon (pediatric tumors, leukemias, linfomas, the adult's embryonic tumors, illness trofoblastic) tumors, but he took a long time more and it was achieved less in the common tumors: he improved a lot the plus life in cancer of he suckles, less that of strain-rectal cancer and almost anything in lung cancer and prostate", explains.
But he adds: "If we evaluate the plus life from the diagnosis, we see that in the common tumors it was duplicated in many cases the time of survival, because they can be diagnosed in more precocious form and because there are better weapons to control the progression speed or worsening of the illness."
In what there was an important advance it is in the quality of life and the control of the symptoms of the incurable patients. "The conservative surgery in cancer of he suckles, right and larynx, the smallest quantity in chemotherapy cycles in numerous tumors and the biggest control in the pain (90% of the patients has the pain controlled with the appropriate use of pain relievers), they are some examples", Eduardo Morgenfeld says in the note granted to daily Trumpet of the day August 12 2003.
For more information please contact us at:
Hector Tanco
Managing Director
LA MORALEJA SRL Laboratory
Street: La Pampa # 2326
5 floor Office #506
Zip Code 1426
City: Buenos Aires
Country: Argentina
Phone: (+54) 11 4706-0503
info@buenodrop.com
Internet: www.buenodrop.com
From the birth of the oncology, in the years 60, different treatments were designed to attack the cancer. They combined surgeries, radiotherapies, chemotherapies, hormonotherapies and immunotherapies, that which allowed important advances.
"Today is possible to cure more some tumors and to try and to alleviate well most of the sick persons", assures doctor Eduardo Morgenfeld, director of Attention to the Patient of the Oncological Institute Henry Moore. However, it clarifies that to be able to speak of "progress" in the cure, one should analyze that happened tumor by tumor.
"It was possible to change the natural history of relatively uncommon (pediatric tumors, leukemias, linfomas, the adult's embryonic tumors, illness trofoblastic) tumors, but he took a long time more and it was achieved less in the common tumors: he improved a lot the plus life in cancer of he suckles, less that of strain-rectal cancer and almost anything in lung cancer and prostate", explains.
But he adds: "If we evaluate the plus life from the diagnosis, we see that in the common tumors it was duplicated in many cases the time of survival, because they can be diagnosed in more precocious form and because there are better weapons to control the progression speed or worsening of the illness."
In what there was an important advance it is in the quality of life and the control of the symptoms of the incurable patients. "The conservative surgery in cancer of he suckles, right and larynx, the smallest quantity in chemotherapy cycles in numerous tumors and the biggest control in the pain (90% of the patients has the pain controlled with the appropriate use of pain relievers), they are some examples", Eduardo Morgenfeld says in the note granted to daily Trumpet of the day August 12 2003.
For more information please contact us at:
Hector Tanco
Managing Director
LA MORALEJA SRL Laboratory
Street: La Pampa # 2326
5 floor Office #506
Zip Code 1426
City: Buenos Aires
Country: Argentina
Phone: (+54) 11 4706-0503
info@buenodrop.com
Internet: www.buenodrop.com
Email
Print
SPAM
LEAVE A COMMENT
